Fusen Pharma board to review interim results, consider dividend

PUBT · 2d ago
Fusen Pharma board to review interim results, consider dividend
  • Board meeting set for Aug. 31, 2026 to review unaudited interim results for the six months ended June 30, 2026.
  • Interim dividend declaration will also be considered.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fusen Pharmaceutical Company Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260819-12290518), on August 19, 2026, and is solely responsible for the information contained therein.